Skip to main content
. 2026 Jul 2;14(7):238. doi: 10.3390/diseases14070238
3TC Lamivudine
ABC Abacavir
AIDS Acquired immunodeficiency syndrome
aOR adjusted Odds Ratio
ART Antiretroviral therapy
ARV Antiretroviral
AZT Zidovudine
CI Confidence Interval
DRC Democratic Republic of Congo
DTG Dolutegravir
EDTA Ethylene-diamine-tetra-acetic acid
EFV Efavirenz
HCFs Healthcare facilities
HIV Human Immunodeficiency Virus
IQR Interquartile Range
LTFU Loss to follow-up
MTCT Mother-to-child transmission
OIs opportunistic infections
OR Odds Ratio
PLHIV People living with HIV
SDGs Sustainable development goals
TDF Tenofovir
UNAIDS Join United Nations Programme on HIV/AIDS
VL Viral Load
WHO World Health Organization